Search
Cronos Group Inc
CRONAdd to Watchlist
2.710USD
+0.040+1.50%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.03BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Cronos Group Inc is 7.00, ranking 112 out of 157 in the Pharmaceuticals industry. The average price target is 2.90, with a high of 2.90 and a low of 2.90.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
3.450
Target Price
+27.31%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Cronos Group Inc
CRON
2
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Cronos Group Inc's expected revenue for the next quarter?
Cronos Group Inc's expected revenue is 44.20M.
What is Cronos Group Inc's price target?
Analysts forecast that Cronos Group Inc's price target is USD 2.90, with the highest forecast at USD 2.90 and the lowest forecast at USD 2.90.
What is the analyst rating for Cronos Group Inc?
Based on the ratings of Cronos Group Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
